{"id":59289,"date":"2015-08-21T11:19:01","date_gmt":"2015-08-21T15:19:01","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=59289"},"modified":"2015-08-21T16:03:32","modified_gmt":"2015-08-21T20:03:32","slug":"pomposity","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2015\/08\/21\/pomposity\/","title":{"rendered":"POM&middot;posity&#8230;"},"content":{"rendered":"<div align=\"justify\" class=\"small\"><font color=\"#200020\"><em><strong>Note<\/strong><\/em>: <strong>POM<\/strong> = <strong>Primary Outcome Measures<\/strong><\/font><\/div>\n<blockquote>\n<div align=\"center\" class=\"big\"><a href=\"http:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0133718\" target=\"_blank\">Is Mandatory Prospective Trial Registration Working  to Prevent Publication of Unregistered Trials and Selective Outcome  Reporting?<\/a><\/div>\n<div align=\"center\" class=\"middle\"><strong><font color=\"#200020\">An Observational Study of Five Psychiatry Journals That  Mandate Prospective Clinical Trial Registration<\/font><\/strong><\/div>\n<div align=\"center\"><strong><span class=\"big\"><font color=\"#000001\">PLoS |<\/font><\/span> <span class=\"middle\"><font color=\"#000001\">ONE<\/font><\/span><\/strong><\/div>\n<div align=\"center\" class=\"middle\">by Amelia Scott, Julia J. Rucklidge, and Roger T. Mulder<\/div>\n<div align=\"center\" class=\"small\">August 19, 2015<\/div>\n<p>                          <\/p>\n<div align=\"justify\"><u><em><strong><font color=\"#200020\">Objective<\/font><\/strong><\/em><\/u>: To  address the bias occurring in the medical literature associated with  selective outcome reporting, in 2005, the International Committee of  Medical Journal Editors [ICMJE] introduced mandatory trial registration  guidelines and member journals required prospective registration of  trials prior to patient enrollment as a condition of publication. No  research has examined whether these guidelines are impacting psychiatry  publications. Our objectives were to determine the extent to which  articles published in psychiatry journals adhering to ICMJE guidelines  were correctly prospectively registered, whether there was evidence of  selective outcome reporting and changes to participant numbers, and  whether there was a relationship between registration status and source  of funding.<\/div>\n<div align=\"justify\"><u><em><strong><font color=\"#200020\">Materials and Methods<\/font><\/strong><\/em><\/u>: Any  clinical trial [as defined by ICMJE] published between 1 January 2009  and 31 July 2013 in the top five psychiatry journals adhering to ICMJE  guidelines [<strong><font color=\"#200020\">The American Journal of Psychiatry<\/font><\/strong>,<strong><font color=\"#200020\"> Archives of General  Psychiatry\/JAMA Psychiatry<\/font><\/strong>,<strong><font color=\"#200020\"> Biological Psychiatry<\/font><\/strong>,<strong><font color=\"#200020\"> Journal of the  American Academy of Child and Adolescent Psychiatry<\/font><\/strong>, and<strong><font color=\"#200020\"> The Journal of  Clinical Psychiatry<\/font><\/strong>] and conducted after July 2005 [or 2007 for two  journals] was included. For each identified trial, where possible we  extracted trial registration information, changes to POMs between  publication and registry to assess selective outcome reporting, changes  to participant numbers, and funding type.   <\/div>\n<div align=\"justify\"><u><em><strong><font color=\"#200020\">Results<\/font><\/strong><\/em><\/u>: Out  of 3305 articles, 181 studies were identified as clinical trials  requiring registration: 21 [11.6%] were deemed unregistered, 61 [33.7%]  were retrospectively registered, 37 [20.4%] had unclear POMs either in  the article or the registry and 2 [1.1%] were registered in an  inaccessible trial registry. Only 60 [33.1%] studies were prospectively  registered with clearly defined POMs; 17 of these 60 [28.3%] showed  evidence of selective outcome reporting and 16 [26.7%] demonstrated a  change in participant numbers of 20% or more; only 26 [14.4%] of the 181  the trials were prospectively registered and did not alter their POMs  or the time frames at which they were measured. Prospective registration  with no changes in POMs occurred more frequently with pharmaceutical  funding.<\/div>\n<div align=\"justify\"><u><em><strong><font color=\"#200020\">Discussion<\/font><\/strong><\/em><\/u>: Although  standards are in place to improve prospective registration and  transparency in clinical trials, less than 15% of psychiatry trials were  prospectively registered with no changes in POMs. Most trials were  either not prospectively registered, changed POMs or the timeframes at  some point after registration or changed participant numbers. Authors,  journal editors and reviewers need to further efforts to highlight the  value of prospective trial registration.<\/div>\n<p>                <\/p>\n<div align=\"justify\">[see also <a target=\"_blank\" href=\"http:\/\/www.madinamerica.com\/2015\/08\/is-mandatory-trial-registration-decontaminating-the-psychiatric-literature\/\">Is Mandatory Trial Registration Decontaminating the Psychiatric Literature?<\/a> by Julia Rucklidge, Ph.D. on <em><font color=\"#200020\">Mad in America<\/font><\/em>].<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">I ended [<a href=\"http:\/\/1boringoldman.com\/index.php\/2015\/08\/17\/post-it-notes\/\" target=\"_blank\">post-it notes&hellip;<\/a>] on the RIAT Initiative with:<\/div>\n<blockquote>\n<div align=\"justify\">So to my post-it notes. <font color=\"#200020\">They add one other vital thing, the a priori study protocol [<\/font>I&rsquo;m 100% serious about the <font color=\"#200020\">vital<\/font>  part]. Among many other things, it lays out what variables will be  assessed and exactly how they will be analyzed. Most, if not all, RCT  distortion involves not following the <font color=\"#200020\">a priori study protocol<\/font> [or having a biased protocol from the start]&#8230;<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">And then this study appears just to show us exactly why the a priori protocol is so <em><strong><font color=\"#200020\">vital<\/font><\/strong><\/em>. The proper sequential procedure in any Clinical Trial involves:<\/div>\n<ol><sup><strong><font color=\"#200020\">           <\/p>\n<div align=\"justify\">&laquo;declare the Primary Outcome Measures&raquo;<\/div>\n<div align=\"justify\">&laquo;register the trial including an a priori protocol&raquo;<\/div>\n<div align=\"justify\">&laquo;conduct the blinded trial&raquo;<\/div>\n<div align=\"justify\">&laquo;break the blind&raquo;<\/div>\n<div align=\"justify\">&laquo;analyze the Primary Outcome Measures according to the a priori protocol&raquo;<\/div>\n<div align=\"justify\">&laquo;report the results&raquo;<\/div>\n<p>              <\/font><\/strong><\/sup><\/ol>\n<div align=\"justify\" class=\"small\"> It&#8217;s pretty cut-and-dried. These investigators looked at the trials that recruited after a defined date and published 2009-2013 in the five major psychiatric journals. They compiled the start date, the registration date, the Primary Outcome Measures [POMs], and whether the declared POMs carried through to the paper itself. This is an abbreviated version of what they found.             <\/div>\n<p align=\"center\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" border=\"0\" height=\"314\" src=\"http:\/\/1boringoldman.com\/images\/rct-3.gif\" \/><br \/>                    <sup>[truncated and rearranged to fit]<\/sup><\/p>\n<p align=\"justify\" class=\"small\">And of the 60 that were preregistered and carried into the&nbsp; publication, only 26 POMs were used without some evidence of jury-rigging [14.1 %]! Pitiful!<\/p>\n<p align=\"justify\" class=\"small\">And ~half of those retrospectively registered trials were registered over a year after the study began. Also pitiful!          <\/p>\n<p align=\"center\"><img decoding=\"async\" width=\"500\" border=\"0\" src=\"http:\/\/1boringoldman.com\/images\/rct-2.jpg\" \/><\/p>\n<p align=\"justify\" class=\"small\">And more&#8230;          <\/p>\n<p align=\"center\" class=\"small\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" border=\"0\" height=\"253\" src=\"http:\/\/1boringoldman.com\/images\/rct-1.jpg\" \/><\/p>\n<div align=\"justify\" class=\"small\">The numbers in the published paper get somewhat confusing to follow, so here&#8217;s the summary from the <a href=\"http:\/\/www.madinamerica.com\/2015\/08\/is-mandatory-trial-registration-decontaminating-the-psychiatric-literature\/\" target=\"_blank\"><em><font color=\"#200020\">Mad in America<\/font><\/em><\/a> article [which is clearer]:<\/div>\n<blockquote>\n<div align=\"justify\">Twenty-one [11.6%] of the 181 studies were deemed unregistered, 61 [33.7%] were retrospectively registered, 37 [20.4%] had unclear POMs  either in the article or the registry and 2 [1.1%] were registered in an  inaccessible trial registry<strong>. <\/strong>Only 60 [33.1%] studies were prospectively registered with clearly defined POMs.<\/div>\n<p>                    <\/p>\n<div align=\"justify\">But seventeen of these 60 [28.3%] properly registered trials showed  evidence of selective outcome reporting &ndash; this means that there had been  changes to POMs based on a comparison of the trial registry and the  publication.<em> In total, only 26 [14.4%] of the 181 trials were  prospectively registered and did not alter their POMs or the time frames  at which they were measure<\/em>d. Prospective registration with no changes in POMs occurred more frequently with pharmaceutical funding.<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">The authors and sponsors bear the ultimate responsibility for this state of affairs, but the editors\/journals share equally in the indictment. They&#8217;re in a position to check these things and insist that they&#8217;re correct. The journal reader has no way to see these parameters in making their judgement about the article. If that weren&#8217;t enough &#8211; these articles in their study are from a time <u>after<\/u> the level of duplicity&nbsp; in clinical trials of psychiatric drugs was becoming well known, well beyond the more gullible era of Study 329, Study 352, Study 15, etc. I guess the inertia of deceit is stronger than the currents of exposure and\/or reform. Data Transparency means including the a priori protocol&#8230;          <\/div>\n<hr size=\"1\" \/>\n<div align=\"justify\"><sup><em><font color=\"#200020\">Parenthetically, having spent some time looking for this kind of data myself, I know that it&#8217;s hard work. A follow-up on how they located all the data for this study would help the rest of us&#8230;<\/font><\/em><\/sup><\/div>\n<hr size=\"1\" \/>\n<div align=\"justify\" class=\"small\"><strong><font color=\"#200020\">Afterthought<\/font><\/strong>: I suppose I should&#8217;ve acknowledged the journals who got it sort of right [actually a bit of a surprise]&#8230;<\/div>\n<p>  <\/p>\n<div align=\"center\"><img decoding=\"async\" width=\"500\" border=\"0\" src=\"http:\/\/1boringoldman.com\/images\/rct-4.jpg\" \/><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Note: POM = Primary Outcome Measures Is Mandatory Prospective Trial Registration Working to Prevent Publication of Unregistered Trials and Selective Outcome Reporting? An Observational Study of Five Psychiatry Journals That Mandate Prospective Clinical Trial Registration PLoS | ONE by Amelia Scott, Julia J. Rucklidge, and Roger T. Mulder August 19, 2015 Objective: To address the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-59289","post","type-post","status-publish","format-standard","hentry","category-opinion"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/59289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=59289"}],"version-history":[{"count":44,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/59289\/revisions"}],"predecessor-version":[{"id":59341,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/59289\/revisions\/59341"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=59289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=59289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=59289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}